Literature DB >> 14555796

Iron concentrations in intestinal cancer tissue and in colon and rectum polyps.

Marek Kucharzewski1, Janusz Braziewicz, Urszula Majewska, Stanislaw Gózdz.   

Abstract

A prospective randomized trial was used to determine iron concentrations in intestinal cancer tissue and colorectum polyps. We investigated the possible difference between the concentrations of iron, ferritin, albumin, and hemoglobin in the serum of patients with colorectal cancer and polyps. We also determined the relationship between the iron and ferritin levels in cancer tissue, the localization of neoplasms, and the stage of their development. The study comprises 67 patients with colorectum cancer and 42 patients with colon and rectum polyps. The metal was determined by using the total-reflection X-ray fluorescence (TRXRF) method. The mean concentration of iron in colorectal cancer equaled 46.1 microg/g of the tissue and was higher than in the case of polyps (43.2 microg/g). The mean serum iron level in patients with colorectal cancer was statistically lower than in the serum of patients with polyp and in the control group (54.5, 91.3, and 108.0 microg/g, respectively). The determined average concentration of ferritin in the serum of patients with colorectal cancer equaled 60.4 microg/g and was statistically lower than the level of this enzyme in the serum of patients with polyps (85.2 microg/g) and in the control group (102.0 microg/g). There was no difference between the serum albumin and hemoglobin concentrations in patients with colorectal cancer, polyps, and the control. There was no difference in the levels of iron and ferritin depending on the location of the neoplasm and the stage of its development. Also, there was no difference between the concentrations of iron in the cancer tissue of malignant and benign tumors after taking into consideration sex and age of patients. During the examination we determined significantly higher concentrations of iron in the cancer tissue and not in the polyp. The low levels of iron in the serum of patients with malignant tumor may increase colorectal cancer risk.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14555796     DOI: 10.1385/BTER:95:1:19

Source DB:  PubMed          Journal:  Biol Trace Elem Res        ISSN: 0163-4984            Impact factor:   3.738


  6 in total

1.  The association between serum ferritin with colorectal cancer.

Authors:  Zhe Feng; Ji-Wei Chen; Jian-Hua Feng; Fei Shen; Wen-Song Cai; Jie Cao; Bo Xu
Journal:  Int J Clin Exp Med       Date:  2015-12-15

2.  Presence of iron in colorectal adenomas and adenocarcinomas.

Authors:  Hye Seung Han; Sun-Young Lee; Moo Kyung Seong; Jeong Hwan Kim; In-Kyung Sung; Hyung Seok Park; Choon Jo Jin; Tae Sook Hwang
Journal:  Gut Liver       Date:  2008-06-30       Impact factor: 4.519

3.  Preoperative iron status is a prognosis factor for stage II and III colorectal cancer.

Authors:  Hiroshi Sawayama; Yuji Miyamoto; Kosuke Mima; Rikako Kato; Katsuhiro Ogawa; Yukiharu Hiyoshi; Mototsugu Shimokawa; Takahiko Akiyama; Yuki Kiyozumi; Shiro Iwagami; Masaaki Iwatsuki; Yoshifumi Baba; Naoya Yoshida; Hideo Baba
Journal:  Int J Clin Oncol       Date:  2021-07-23       Impact factor: 3.402

4.  Dietary phytate lowers K-ras mutational frequency, decreases DNA-adduct and hydroxyl radical formation in azoxymethane-induced colon cancer.

Authors:  Poorna Venkata Satya Prasad Pallem; Sreedhar Bodiga; Vijaya Lakshmi Bodiga
Journal:  Iran J Basic Med Sci       Date:  2020-01       Impact factor: 2.699

5.  Concentrations of cadmium and selected essential elements in malignant large intestine tissue.

Authors:  Michał Klimczak; Adam Dziki; Anna Kilanowicz; Andrzej Sapota; Joanna Duda-Szymańska; Adam Daragó
Journal:  Prz Gastroenterol       Date:  2015-06-29

Review 6.  A systematic review and meta-analysis on the association of serum and tumor tissue iron and risk of breast cancer.

Authors:  Akram Sanagoo; Faezeh Kiani; Marzieh Saei Gharenaz; Fatemeh Sayehmiri; Fatemeh Koohi; Leila Jouybari; Majjid Dousti
Journal:  Caspian J Intern Med       Date:  2020
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.